Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Environ Pollut ; 242(Pt B): 1693-1701, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30086990

ABSTRACT

Ambient particulate matter (PM) epidemiologically exacerbates respiratory and immune health, including allergic rhinitis (AR) and bronchial asthma (BA). Although fine and coarse particles can affect respiratory tract, the differences in their effects on the upper and lower respiratory tract and immune system, their underlying mechanism, and the components responsible for the adverse health effects have not been yet completely elucidated. In this study, ambient fine and coarse particles were collected at three different locations in Japan by cyclone technique. Both particles collected at all locations decreased the viability of nasal epithelial cells and antigen presenting cells (APCs), increased the production of IL-6, IL-8, and IL-1ß from bronchial epithelial cells and APCs, and induced expression of dendritic and epithelial cell (DEC) 205 on APCs. Differences in inflammatory responses, but not in cytotoxicity, were shown between both particles, and among three locations. Some components such as Ti, Co, Zn, Pb, As, OC (organic carbon) and EC (elemental carbon) showed significant correlations to inflammatory responses or cytotoxicity. These results suggest that ambient fine and coarse particles differently affect nasal and bronchial epithelial cells and immune response, which may depend on particles size diameter, chemical composition and source related particles types.


Subject(s)
Air Pollutants/toxicity , Epithelial Cells/drug effects , Immune System/drug effects , Particulate Matter/toxicity , Air Pollutants/analysis , Asthma/chemically induced , Bronchi/drug effects , Carbon , Environmental Exposure , Humans , Japan , Particle Size
2.
J Antibiot (Tokyo) ; 55(2): 155-64, 2002 Feb.
Article in English | MEDLINE | ID: mdl-12002997

ABSTRACT

Two novel compounds, stachyflin and acetylstachyflin, have been isolated by solid-state fermentation of Stachybotrys sp. RF-7260. The structures of both metabolites, determined by detailed NMR analyses and X-ray crystallographic analysis, are novel with a pentacyclic moiety including cis-fused decalin. The absolute stereochemistry of stachyflins was determined by circular dichroism analysis. Stachyflin showed antiviral activity against influenza A virus (H1N1) in vitro with an IC50 value of 0.003 microM. Acetylstachyflin was about 77-fold less active than stachyflin.


Subject(s)
Antiviral Agents/chemistry , Heterocyclic Compounds, 4 or More Rings/chemistry , Indoles/chemistry , Sesquiterpenes/chemistry , Antiviral Agents/isolation & purification , Antiviral Agents/pharmacology , Fermentation , Heterocyclic Compounds, 4 or More Rings/isolation & purification , Heterocyclic Compounds, 4 or More Rings/pharmacology , Indoles/isolation & purification , Indoles/pharmacology , Influenza A virus/drug effects , Molecular Structure , Sesquiterpenes/isolation & purification , Sesquiterpenes/pharmacology , Structure-Activity Relationship
3.
J Antibiot (Tokyo) ; 55(3): 239-48, 2002 Mar.
Article in English | MEDLINE | ID: mdl-12014438

ABSTRACT

Stachybotrys sp. RF-7260 was found to produce stachyflins, novel anti-influenza virus agents, under solid-state fermentation conditions. Feeding DL-lysine to a culture of Stachybotrys sp. RF-7260 induced the formation of the novel compounds, SQ-02-S-L2 and -L1, and feeding DL-valine the formation of SQ-02-S-VI and -V2. The structures of these metabolites were determined by detailed 2D NMR analyses in comparison with acetylstachyflin. SQ-02-S-L2 and -L1 have the lysine moiety and SQ-02-S-V1 has the valine moiety. SQ-02-S-V2 has an amidine moiety instead of the lactam moiety in acetylstachyflin. SQ-02-S-L2, -L1 and -V1, substituted on the lactam amide hydrogen, displayed only a low level of the antiviral activity. However, deacetyl SQ-02-S-V2 showed potent antiviral activity similar to stachyflin.


Subject(s)
Antiviral Agents/chemistry , Heterocyclic Compounds, 4 or More Rings/chemistry , Indoles/chemistry , Sesquiterpenes/chemistry , Stachybotrys/metabolism , Animals , Antiviral Agents/isolation & purification , Antiviral Agents/pharmacology , Cattle , Cell Line , Fermentation , Heterocyclic Compounds, 4 or More Rings/isolation & purification , Heterocyclic Compounds, 4 or More Rings/pharmacology , Indoles/isolation & purification , Indoles/pharmacology , Influenza A virus/drug effects , Kidney/cytology , Sesquiterpenes/isolation & purification , Sesquiterpenes/pharmacology , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...